The dominant expression of CYP2A13 in human bronchial epithelium [12] and its high efficiency in the metabolic activation of tobacco-specific carcinogenic NNK are consistent with observations that most smoking-related lung cancers are bronchogenic [42]. This evidence concerns the gene CYP2A13 and lung carcinoma.